アンジオテンシンタイプ2受容体を介した血管弛緩機構
スポンサーリンク
概要
- 論文の詳細を見る
Angiotensin II (Ang II) signaling is mediated by two receptor subtypes, type 1 (AT_1) and type 2 (AT_2). The activation of AT_1 receptors is responsible for the development of Ang II-dependent hypertension, whereas the activation of AT_2 receptor is thought to play a counter-regulatory protective role in the regulation of blood pressure that opposes the AT_1 receptor-mediated vasoconstriction. However, the precise mechanisms by which increased numbers of AT_2 receptors counterbalance the AT_1-mediated actions of Ang II are unknown. We have demonstrated that the abdominal aortic banding in mice and rats and the 2-kidney, 1-clip Goldblatt model of hypertension in mice induces up-regulation of AT_2 receptors in the pressure-overloaded thoracic aorta. In these hypertensive animals, the AT_1-receptor antagonists but not calcium antagonist abolish up-regulation of the aortic AT_2 receptor as well as blood pressure elevation, suggesting that the pressure-overload up-regulates the aortic AT_2 receptor by Ang II via the activation of AT_1 receptor. Ang II binding to up-regulated AT_2 receptors induces vasodilation in these aortas through bradykinin B_2-receptor-mediated phosphorylation of endothelial nitric oxide synthase (eNOS) at Ser^<633> and Ser^<1177> via a protein kinase A-dependent signaling pathway, resulting in sustained production of nitric oxide. These studies provide evidence that the vascular AT_2 receptor is up-regulated in the course of hypertension through the activation of AT_1 receptor, thereby activating a vasodilatory pathway in vessels through the AT_2 receptor via the bradykinin/nitric oxide/cGMP. This issue is important because the antihypertensive effect of AT_1-receptor blockers is, at least in part, dependent on AT_2-receptor activation.
- 社団法人日本薬学会の論文
- 2007-09-01
著者
関連論文
- アンジオテンシンタイプ2受容体を介した血管弛緩機構
- アンジオテンシンタイプ2受容体を介した血管弛緩機構
- 循環調節因子に関する最近の進歩
- Role of Angiotensin II in the Transforming Growth Factor-β1 Expression of Rat Kidney in Anti-Glomerular Basement Membrane Antiserum-Induced Glomerulonephritis
- Activation of the Renin-Angiotensin System in Anti-glomerular Basement Membrane Antibody-Induced Glomerulonephritis
- Angiotensinogen Synthesis in the Liver Is Independent of Physiological Estrogen Levels
- Endotoxin-Induced Enhancement of Angiotensinogen Synthesis in hte Liver : Decreased Response Following Repeated Endotoxin Exposure
- STUDY ON THE ACTION OF PERCUTANEOUS PENETRATION ENHANCERS : EFFECT ON VARIOUS DRUGS WITH DIFFERENT PHYSICOCHEMICAL PROPERTIES
- 無菌ラットにおけるリポポリサッカライド投与の血清中IL-1およびコルチコステロンレベルに及ぼす影響
- 無菌ラット血清および腹腔内マクロファージにおけるリポポリサッカライド投与のTNF, IL-6レベルに及ぼす影響
- リポポリサッカライドによる炎症性刺激に対する無菌マウスの応答性
- 無菌マウスにおけるリポポリサッカライド投与のserum amyloid A および血清中 TNF レベルに及ぼす影響
- Preparation of Dry Powder Inhalation with Lactose Carrier Particles Surface-Coated Using a Wurster Fluidized Bed
- Effects of Surface Processing of Lactose Carrier Particles on Dry Powder Inhalation Properties of Salbutamol Sulfate
- Influence of Storage Humidity on the in Vitro Inhalation Properties of Salbutamol Sulfate Dry Powder with Surface Covered Lactose Carrier
- Effect of Surface Layering Time of Lactose Carrier Particles on Dry Powder Inhalation Properties of Salbutamol Sulfate
- Effect of Surface Covering of Lactose Carrier Particles on Dry Powder Inhalation Properties of Salbutamol Sulfate
- Preparation of Dry Powder Inhalation by Surface Treatment of Lactose Carrier Particles
- Evaluation of Flow Properties of Dry Powder Inhalation of Salbutamol Sulfate with Lactose Carrier
- Angiotensin II Regulates Liver Regeneration via Type 1 Receptor Following Partial Hepatectomy in Mice(Pharmacology)
- Preparation of Functional Composite Particles of Salbutamol Sulfate Using a 4-Fluid Nozzle Spray-Drying Technique
- Particle Design of Three-Component System for Sustained Release Using a 4-Fluid Nozzle Spray-Drying Technique
- Particle Design Using a 4-Fluid-Nozzle Spray-Drying Technique for Sustained Release of Acetaminophen
- Acetaminophen Particle Design Using Chitosan and a Spray-Drying Technique
- Improved Dissolution of an Insoluble Drug Using a 4-Fluid Nozzle Spray-Drying Technique
- Expression of Low-Molecular-Weight Kininogen in Mouse Vascular Smooth Muscle Cells
- Tissue-Specific Expression of Rat Kininogen mRNAs
- Expression of Low-Molecular-Weight Kininogen mRNA in Human Fibroblast WI38 Cells
- Angiotensin-Converting Enzyme Inhibitor Enhances Liver Regeneration Following Partial Hepatectomy : Involvement of Bradykinin B_2 and Angiotensin AT_1 Receptors(Pharmacology)
- The Lipopolysaccharide-Induced Up-Regulation of Bradykinin B_2-Receptor in the Mouse Heart Is Mediated by Tumor Necrosis Factor-α and Angiotensin II(Pharmacology)
- Expressions of Bradykinin B2-Receptor, Kallikrein and Kininogen mRNAs in the Heart Are Altered in Pressure-Overload Cardiac Hypertrophy in Mice
- アンジオテンシン(1-7)
- 組織カリクレインの構造と特異性
- アンジオテンシン変換酵素阻害薬の心保護作用にキニンは関与するか?